Presentations & Publications
Recent Presentations & Publications
- Webcast Link to 2021 Third Quarter Earnings Financial Results Conference Call - Friday, November 12, 2021 at 8:30 a.m. ET
- Webcast Link to 2021 Second Quarter Earnings Financial Results Conference Call – Friday, August 13, 2021 at 8:30 a.m. ET
- Webcast Link to 2021 First Quarter Earnings Financial Results Conference Call – Friday, May 14, 2021 at 8:30 a.m. ET
- Corporate Presentation March 2021
- Webcast Link to 2020 Year End Earnings 2020 Financial Results Conference Call – Wednesday, March 10, 2021 at 8:30 a.m. ET
- Annual Shareholders Presentation Slides - December 2020
- Webcast Link to Third Quarter 2020 Financial Results Conference Call - Friday November 13, 2020 @ 8:30 a.m. ET
- Corporate Presentation September 2020
- Webcast Link to Second Quarter 2020 Financial Results Conference Call - Friday, August 14, 2020 at 8:30 a.m. ET
- STONEGATE Capital Partners December 4, 2019 Report
- H.C. Wainwright / BPTH: Safety Testing of Phase 2 AML Trial Completed; Financing Closed; Reiterate Buy; Adjusting PT to $25
- Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) – January 2019
- Stonegate Capital Partners Research Report - August 2018
- BP1001 phase I-Ib protocol
- Drug Development and Delivery Published Article: DNA THERAPEUTICS - DNAbilize-ING Antisense
- Published Article: Evolution of Antisense Oligonucleotides in Oncology
- Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01
- OncLive interview with Dr. Cortes on BP-100.01 in Patients with Relapsed/Refractory AML
- Bio-Path Hopes to Blaze Profitable Path With Antisense Drugs - January 2016